USPTO trademark

DYSPORT ABOBOTULINUMTOXINA DYSCOVERY

Under examinationUSPTOWord markClass 41Class 42

"DYSPORT ABOBOTULINUMTOXINA DYSCOVERY" is a word mark owned by Ipsen Biopharm Limited, filed at the USPTO on October 26, 2026. It is under examination and covers classes 41 and 42.

Official USPTO record
DYSPORT ABOBOTULINUMTOXINA DYSCOVERY trademark as filed
As filed with the USPTO
Status
Under examination
Since October 26, 2026
Filed
October 26, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50181395
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns DYSPORT ABOBOTULINUMTOXINA DYSCOVERY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services DYSPORT ABOBOTULINUMTOXINA DYSCOVERY is filed for, grouped by Nice class.

  • Educational services, namely, providing in-person and online courses and training in the field of healthcare; providing personalized in-person and online educational courses and training in the field of healthcare based on users' profiles, interests, and engagement; educational services, namely, providing educational and training programs for healthcare professionals in the field of healthcare

  • Providing temporary use of online non-downloadable software featuring artificial intelligence for providing personalized educational content and recommending educational courses based on users' profiles, interests, and engagement; providing temporary use of online non-downloadable software for curating and recommending educational and training content for healthcare professionals

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About DYSPORT ABOBOTULINUMTOXINA DYSCOVERY

Who owns the trademark "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY"?

The USPTO trademark "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY" (application 50181395) is owned by Ipsen Biopharm Limited.

What is the status of "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DYSPORT ABOBOTULINUMTOXINA DYSCOVERY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a17d7a-b4f4-7472-93e0-6af72f8f468b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a17d7a-b4f4-7472-93e0-6af72f8f468b",
  "object": "trademark",
  "mark_text": "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50181395",
  "filing_date": "2026-10-26",
  "nice_classes": [
    41,
    42
  ],
  "owners": [
    {
      "name": "IPSEN BIOPHARM LIMITED",
      "entity_id": "ent_019eb708-e440-75d9-a932-4d18c18228d2"
    }
  ]
}